Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline discloses novel EZH2 inhibitors

Nov. 17, 2017

Bayer discovers new vasopressin receptor antagonists

Nov. 17, 2017

OncoArendi Therapeutics patents arginase inhibitors

Nov. 17, 2017

Rudong SIMR Biotech presents new GABRA5 inverse agonists

Nov. 16, 2017

Inception 1 discovers novel NADPH oxidase 4 inhibitors

Nov. 16, 2017

Novel vasopressin V1A and V2 receptor antagonists developed at Bayer

Nov. 16, 2017

Roche, Genentech describe new Janus kinase inhibitors

Nov. 16, 2017

Samumed patents novel Wnt signaling inhibitors

Nov. 16, 2017

New yohimbine analogues synthesized at the University of Florida

Nov. 15, 2017

The University of Texas discovers novel sigma1/2 receptor antagonists

Nov. 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...